Xenon Pharmaceuticals Inc.

Capital World Investors XENE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

655,737

Value ($000)

29,390

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	29,390	0.0%	655,737	12/31/2025
2025 Q3	11/13/2025	26,328	0.0%	655,737	9/30/2025
2025 Q2	8/13/2025	20,525	0.0%	655,737	6/30/2025
2025 Q1	5/12/2025	74,639	0.0%	2,224,715	3/31/2025
2024 Q4	2/13/2025	89,946	0.0%	2,294,537	12/31/2024
2024 Q3	11/13/2024	105,572	0.0%	2,681,537	9/30/2024
2024 Q2	8/13/2024	104,553	0.0%	2,681,537	6/30/2024
2024 Q1	5/14/2024	115,440	0.0%	2,681,537	3/31/2024
2023 Q4	2/13/2024	123,512	0.0%	2,681,537	12/31/2023
2023 Q3	11/13/2023	77,713	0.0%	2,274,974	9/30/2023
2023 Q2	8/11/2023	87,586	0.0%	2,274,974	6/30/2023
2023 Q1	5/15/2023	81,421	0.0%	2,274,974	3/31/2023
2022 Q4	2/14/2023	89,702	0.0%	2,274,974	12/31/2022
2022 Q3	11/14/2022	82	0.0%	2,274,974	9/30/2022
2022 Q2	8/15/2022	69	0.0%	2,274,974	6/30/2022
2022 Q1	5/19/2022	70	0.0%	2,274,974	3/31/2022
2021 Q4	2/14/2022	71	0.0%	2,274,974	12/31/2021
2021 Q3	11/15/2021	15	0.0%	963,500	9/30/2021
2021 Q2	8/16/2021	18	0.0%	963,500	6/30/2021
2021 Q1	5/14/2021	17	0.0%	963,500	3/31/2021
2020 Q4	2/12/2021	15	0.0%	963,500	12/31/2020
2020 Q3	11/13/2020	11	0.0%	963,500	9/30/2020
2020 Q2	8/14/2020	12	0.0%	963,500	6/30/2020
2020 Q1	5/15/2020	11	0.0%	963,500	3/31/2020
2019 Q4	2/18/2020	13	0.0%	963,500	12/31/2019